IXC 6.67% 8.0¢ invex therapeutics ltd

Ann: Phase III Clinical Trial Update and New IIH Market Analysis, page-99

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 8,554 Posts.
    lightbulb Created with Sketch. 1404
    I'm not aware of any example of a biotech voluntarily returning cash after winding up a trial.

    Even equity investment companies trading at well below NTA rarely voluntarily wind up.

    Anyway, IXC aren't going to even consider it until they very belatedly find out what the TAM is.
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.